✦ LIBER ✦

Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of observational studies

✍ Scribed by Remi Kouz; Simon Kouz; Erick Schampaert; Stephane Rinfret; Jean-Claude Tardif; Michel Nguyen; Mark Eisenberg; Richard Harvey; Marc Afilalo; Claude Lauzon; Jean-Pierre Dery; Samer Mansour; Thao Huynh

Book ID: 116549424
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 759 KB
Volume: 153
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2010.08.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early vs. late administration of glycopr

Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction. A meta-analysis

✍ G. Montalescot; M. Borentain; L. Payot; J.P. Collet; D. Thomas 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Prospective evaluation of glycoprotein I

Prospective evaluation of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing percutaneous coronary intervention for ST-segment elevation myocardial infarction

✍ P Lachance; J.-P. Déry; S Grenier; G Barbeau; B Noël; É Larose; J Rodés-Cabau; O 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Usefulness of Routine Unfractionated Hep

Usefulness of Routine Unfractionated Heparin Infusion Following Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients Not Receiving Glycoprotein IIb/IIIa Inhibitors

✍ Kishore J. Harjai; Gregg W. Stone; Cindy L. Grines; David A. Cox; Eulogio Garcia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 121 KB

AS-77: Clinical Benefits of Glycoprotein

AS-77: Clinical Benefits of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Elevation Myocardial Infarction Pretreated with Clopidogrel before Primary Percutaneous Coronary Intervention

✍ Doo Sun Sim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Timing of Glycoprotein IIb/IIIa Inhibito

Timing of Glycoprotein IIb/IIIa Inhibitor Use and Outcomes Among Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (Results from CRUSADE)

✍ Pierluigi Tricoci; Eric D. Peterson; Anita Y. Chen; L. Kristin Newby; Robert A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Safety and efficacy of glycoprotein IIb/

Safety and efficacy of glycoprotein IIb/IIIa inhibitors in patients treated with percutaneous coronary intervention early after receiving thrombolytic therapy

✍ W. Jaber; C.S. Rihal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB